1. Pacak K, Timmers HJ, Eisenhofer G. Jameson JL, De Groot LJ, editors. Pheochromoyotma. Endocrinology. 2010. 6th ed. Philadelphia: Saunders Elsevier;1990–2018.
2. William FY Jr. Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, editors. Endocrine hypertension. Williams Textbook of Endocrinology. 2011. 12th ed. Philadelphia: Elsevier Saunders;545–577.
3. Neumann HP. Longo DL, Fauci A, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Pheochromocytoma. Harrison's Principles of Internal Medicine. 2011. 18th ed. New York: McGraw-Hill;2962–2967.
4. Song YD. Korean Endocrine Society. Adrenal cortex and endocrine hypertension. Texbook of Endocrinology and Metabolism. 2011. 2nd ed. Seoul: Koonja Publishing;342–375.
5. Sung YA. Adrenal incidentaloma. J Korean Soc Endocrinol. 1999. 14:433–439.
6. Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL. Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland Clinic experience. J Clin Endocrinol Metab. 2005. 90:871–877.
7. Blake MA, Cronin CG, Boland GW. Adrenal imaging. AJR Am J Roentgenol. 2010. 194:1450–1460.
8. Taffel M, Haji-Momenian S, Nikolaidis P, Miller FH. Adrenal imaging: a comprehensive review. Radiol Clin North Am. 2012. 50:219–243.
9. Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology. 1998. 207:369–375.
10. Ramsay JA, Asa SL, van Nostrand AW, Hassaram ST, de Harven EP. Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors. Am J Surg Pathol. 1987. 11:480–486.
11. Blake MA, Krishnamoorthy SK, Boland GW, Sweeney AT, Pitman MB, Harisinghani M, Mueller PR, Hahn PF. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR Am J Roentgenol. 2003. 181:1663–1668.
12. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA. 2002. 287:1427–1434.
13. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005. 366:665–675.
14. Eisenhofer G. Screening for pheochromocytomas and paragangliomas. Curr Hypertens Rep. 2012. 14:130–137.
15. Yoo SJ. Diagnosis and treatment of pheochromocytoma. Korean J Med. 2012. 82:403–410.
16. Kim HY, Kim SG, Lee KW, Seo JA, Kim NH, Choi KM, Baik SH, Choi DS. Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med. 2005. 20:303–309.
17. Jeong HS, Kim HJ, Kim HS, Kim SW, Shin CS, Park DJ, Park KS, Jang HC, Kim SY, Cho BY, Lee HK. Clinical characteristics for 132 patients with adrenal incidentaloma. J Korean Endocr Soc. 2007. 22:260–265.
18. Kim SG, Choi DS. The evaluation and follow-up of adrenal incidentaloma. J Korean Endocr Soc. 2007. 22:257–259.
19. Kim YA, Hwangbo Y, Kim MJ, Choi HJ, Seo JH, Lee Y, Kwak SH, Ku EJ, Oh TJ, Roh E, Bae JH, Kim JH, Park KS, Kim SY. Characterization of incidentally detected adrenal pheochromocytoma. Endocrinol Metab. 2012. 27:132–137.